Children and adolescents discharge guidelines after allogeneic stem cell transplantation for healthcare professionals : Recommendations of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)
Copyright © 2019 Société Française du Cancer. Published by Elsevier Masson SAS. All rights reserved..
Recommendations for visits or environment restrictions, and sometimes for food are usually well described for inpatient within HSCT unit procedures where those measures are less precise and detailed for outpatient from the discharge to the immune reconstitution achievement. The present paper main objective is to define risk patient groups depending on time, immune-suppressive drugs as well as graft-versus-host disease and immune reconstitution. We define here 3 risk patient groups and propose measures about house cleaning, pets, schools, social activities, hygiene, foods, sexual life and siblings.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:107 |
---|---|
Enthalten in: |
Bulletin du cancer - 107(2020), 1S vom: 15. Jan., Seite S62-S67 |
Sprache: |
Französisch |
---|
Weiterer Titel: |
Consignes de vie après allogreffe de cellules souches hématopoïétiques chez l’enfant, l’adolescent et le jeune adulte, à l’usage des professionnels : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC) |
---|
Beteiligte Personen: |
Sirvent, Anne [VerfasserIn] |
---|
Links: |
---|
Themen: |
Consensus Development Conference |
---|
Anmerkungen: |
Date Completed 03.03.2020 Date Revised 04.12.2021 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.bulcan.2019.03.006 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM296207896 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM296207896 | ||
003 | DE-627 | ||
005 | 20231225085335.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||fre c | ||
024 | 7 | |a 10.1016/j.bulcan.2019.03.006 |2 doi | |
028 | 5 | 2 | |a pubmed24n0987.xml |
035 | |a (DE-627)NLM296207896 | ||
035 | |a (NLM)31000319 | ||
035 | |a (PII)S0007-4551(19)30157-2 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a fre | ||
100 | 1 | |a Sirvent, Anne |e verfasserin |4 aut | |
245 | 1 | 0 | |a Children and adolescents discharge guidelines after allogeneic stem cell transplantation for healthcare professionals |b Recommendations of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC) |
246 | 3 | 3 | |a Consignes de vie après allogreffe de cellules souches hématopoïétiques chez l’enfant, l’adolescent et le jeune adulte, à l’usage des professionnels : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC) |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 03.03.2020 | ||
500 | |a Date Revised 04.12.2021 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2019 Société Française du Cancer. Published by Elsevier Masson SAS. All rights reserved. | ||
520 | |a Recommendations for visits or environment restrictions, and sometimes for food are usually well described for inpatient within HSCT unit procedures where those measures are less precise and detailed for outpatient from the discharge to the immune reconstitution achievement. The present paper main objective is to define risk patient groups depending on time, immune-suppressive drugs as well as graft-versus-host disease and immune reconstitution. We define here 3 risk patient groups and propose measures about house cleaning, pets, schools, social activities, hygiene, foods, sexual life and siblings | ||
650 | 4 | |a Consensus Development Conference | |
650 | 4 | |a Journal Article | |
650 | 4 | |a Practice Guideline | |
650 | 4 | |a Consignes: Postgreffe | |
650 | 4 | |a Discharge recommendations | |
650 | 4 | |a HSCT | |
650 | 4 | |a Pediatrics | |
650 | 4 | |a Professionnels | |
650 | 4 | |a Pédiatrie | |
700 | 1 | |a Delorme, Josiane |e verfasserin |4 aut | |
700 | 1 | |a Godin, Sandrine |e verfasserin |4 aut | |
700 | 1 | |a Grain, Audrey |e verfasserin |4 aut | |
700 | 1 | |a Jubert, Charlotte |e verfasserin |4 aut | |
700 | 1 | |a Pertuisel, Sophie |e verfasserin |4 aut | |
700 | 1 | |a Pochon, Cécile |e verfasserin |4 aut | |
700 | 1 | |a Tardieu, Laure |e verfasserin |4 aut | |
700 | 1 | |a Yakoub-Agha, Ibrahim |e verfasserin |4 aut | |
700 | 1 | |a Dalle, Jean-Hugues |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Bulletin du cancer |d 1966 |g 107(2020), 1S vom: 15. Jan., Seite S62-S67 |w (DE-627)NLM000155853 |x 1769-6917 |7 nnns |
773 | 1 | 8 | |g volume:107 |g year:2020 |g number:1S |g day:15 |g month:01 |g pages:S62-S67 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.bulcan.2019.03.006 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 107 |j 2020 |e 1S |b 15 |c 01 |h S62-S67 |